Last update 21 Nov 2024

Wiskott-Aldrich Syndrome therapy (ImmunoVec)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
Autologous CD34+ hematopoietic stem and progenitor cells modified ex vivo with a lentiviral vector that restores endogenously regulated expression of WASp
Target
CD34
Mechanism
CD34 modulators(Hematopoietic progenitor cell antigen CD34 modulators)
Therapeutic Areas
Immune System DiseasesCongenital DisordersHemic and Lymphatic Diseases+ [1]
Active Indication
Wiskott-Aldrich Syndrome
Inactive Indication-
Originator Organization
ImmunoVec, Inc.ImmunoVec, Inc.
Active Organization
ImmunoVec, Inc.ImmunoVec, Inc.
Inactive Organization-
Drug Highest PhaseDiscovery
First Approval Date-
RegulationOrphan Drug (US)

Related

100 Clinical Results associated with Wiskott-Aldrich Syndrome therapy (ImmunoVec)
Login to view more data
100 Translational Medicine associated with Wiskott-Aldrich Syndrome therapy (ImmunoVec)
Login to view more data
100 Patents (Medical) associated with Wiskott-Aldrich Syndrome therapy (ImmunoVec)
Login to view more data
1
Literatures (Medical) associated with Wiskott-Aldrich Syndrome therapy (ImmunoVec)
Haematologica
A first-in-class Wiskott-Aldrich syndrome protein activator with anti-tumor activity in hematologic cancers
100 Deals associated with Wiskott-Aldrich Syndrome therapy (ImmunoVec)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wiskott-Aldrich SyndromeDiscovery
US
ImmunoVec, Inc.ImmunoVec, Inc.
18 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free